
A Success Story - Delveinsight's Strategic Support To A Biopharma Leader In NSCLC Epidemiology Forecasting Up To 2034, ...
(MENAFN- PR Newswire) In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small cell lung cancer (NSCLC) turned to DelveInsight, a trusted name in healthcare …